Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu

-Mandeep Singh, Global Head of Tech Research for Bloomberg Intelligence, discusses top tech stories. Nvidia Corp.'s stock is the cheapest it's been since before the AI boom, after losing roughly $1 trillion in market value in less than two months. The AI rotation trade is also gathering pace in Asia as investors pull money from chipmakers and hunt for cheaper ways to play the technology boom.

-Robert Schiffman, Senior Tech Credit Analyst for Bloomberg Intelligence, discusses Amazon’s debt sale. Amazon.com is tapping the US high-grade bond market for the second time this year even after issuing more than $60 billion across currencies and accumulating nearly $155 billion in pro forma cash, underscoring the scale of its AI funding needs.

-Anurag Rana, Senior Tech Analyst for Bloomberg Intelligence, discusses Apple saying its expanded agreement with Broadcom is expected to top $30 billion. The deal will involve manufacturing more than 15 billion chips in the US, supporting hundreds of jobs, and Apple will help Broadcom upgrade its production facilities in Colorado.

See omnystudio.com/listener for privacy information.

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Stacey Vanek Smith

-Ed Ludlow, BTech Anchor, discusses top tech stories. Samsung Electronics Co.’s quarterly profit surged, prompting investors to cash out of a near-150% rally this year that had baked in the AI-fueled growth.
Separately, Amazon.com Inc. is looking to raise at least $25 billion from a US dollar bond sale to fund spending on artificial intelligence infrastructure.

-Ryan Vlastelica, Bloomberg Equities Reporter, discusses why the Mag 7 tech giants are no longer dominating the stock market, with their index gaining just 1.7% in 2026. Investors are now focused on the biggest beneficiaries of the wave of cash dedicated to building out AI, such as memory chipmakers like Micron Technology Inc. and Sandisk Corp.

-- Gautam Mukunda, Lecturer at Yale School of Management and Bloomberg Opinion contributor, discusses his column: “Sam Altman Offers a Trojan Horse to America.” Sam Altman offered the US government a 5% stake in OpenAI, which he said would allow Americans to share in the benefits of artificial intelligence. The offer is seen as a way for OpenAI to "capture" the government and gain an advantage through regulatory capture, where the government becomes an owner of the company and has an economic stake in its success.

See omnystudio.com/listener for privacy information.

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu

- Brody Ford, Bloomberg Technology Reporter, discusses Microsoft Corp.'s Xbox plans to eliminate 3,200 jobs, or around 20% of its staff over the next year, as part of a massive reorganization to spur growth in the struggling gaming division. Xbox will divest four of its video-game development studios and is beginning the process to part ways with a fifth, with the goal of streamlining the business and reinvesting in bigger projects.

- Bailey Lipschultz, Bloomberg News Senior Equities Reporter, discusses SK Hynix kicking off the formal marketing process for its US listing, seeking to sell American depositary receipts representing about 17.79 million common shares. The company is looking to capitalize on surging investor demand for the high-flying memory-chip sector, with the offering of ADRs coming after the firm’s Seoul-traded stock rallied about 260% this year.

- Tim Craighead, Bloomberg Intelligence Global Chief Content Officer, discusses 10 companies to watch in Q3. Bloomberg Intelligence analysts have identified interesting companies from their roster of high-confidence Focus Ideas. Spanning sectors and regions, each scenario outlines a catalyst in the next few months that supports our case.

- Sam Fazeli, Bloomberg Intelligence Director of Research: Healthcare, Defence, Industrials & Autos, discusses Novartis AG agreeing to buy Myricx Bio for as much as $1.5 billion, adding an experimental cancer drug designed to deliver more potent treatments directly to tumors while limiting damage to healthy cells.

See omnystudio.com/listener for privacy information.